Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling
Authors
Keywords
HDACs, GBM, SMAD2, p21
Journal
TUMOR BIOLOGY
Volume 36, Issue 12, Pages 9661-9665
Publisher
Springer Nature
Online
2015-07-07
DOI
10.1007/s13277-015-3747-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience
- (2014) Pavel Bezecny MEDICAL ONCOLOGY
- M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7
- (2014) Xiangwei Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation
- (2014) Shengquan Huang et al. TUMOR BIOLOGY
- EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2
- (2014) Shaoyi Li et al. TUMOR BIOLOGY
- MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma
- (2014) Fei Wang et al. TUMOR BIOLOGY
- Inhibition of FoxO1 nuclear exclusion prevents metastasis of Glioblastoma
- (2014) Jin Chen et al. TUMOR BIOLOGY
- HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells
- (2013) Hui Jin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- HDAC inhibitors and their potential applications to glioblastoma therapy
- (2013) Eleni Adamopoulou et al. OncoImmunology
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?
- (2012) Sabrina Ehnert et al. BMC Medicine
- Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts
- (2012) J.-S. Cho et al. CLINICAL AND EXPERIMENTAL ALLERGY
- TGF Receptor Signaling Is Essential for Inflammation-Induced but Not -Cell Workload-Induced -Cell Proliferation
- (2012) X. Xiao et al. DIABETES
- P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells
- (2012) K. Bajbouj et al. JOURNAL OF NEURO-ONCOLOGY
- USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
- (2012) Pieter J A Eichhorn et al. NATURE MEDICINE
- Nuclear Smad7 Overexpressed in Mesenchymal Cells Acts as a Transcriptional Corepressor by Interacting with HDAC-1 and E2F to Regulate Cell Cycle
- (2012) T. Emori et al. Biology Open
- MAP Kinase-Interacting Kinase 1 Regulates SMAD2-Dependent TGF- Signaling Pathway in Human Glioblastoma
- (2011) M. Grzmil et al. CANCER RESEARCH
- Blockade of TGF- Signaling by the TGF R-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma
- (2011) M. Zhang et al. CANCER RESEARCH
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma
- (2010) Judit Anido et al. CANCER CELL
- TGF-β Signaling Specifies Axons during Brain Development
- (2010) Jason J. Yi et al. CELL
- HDAC-mediated control of ERK- and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes
- (2010) Matt J. Barter et al. MATRIX BIOLOGY
- TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
- (2010) Kazuhito Naka et al. NATURE
- TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma
- (2009) Silvia Peñuelas et al. CANCER CELL
- TGFβ in Cancer
- (2008) Joan Massagué CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started